{"id":"W2028849325","doi":"10.1007/s00280-011-1755-0","title":"A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"Pfizer","keywords":"Medicine; Pemetrexed; Sunitinib; Neutropenia; Lung cancer; Internal medicine; Dosing; Pharmacokinetics; Adverse effect; Febrile neutropenia; Oncology; Cancer; Pharmacology; Chemotherapy; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001395308,0.001283695,0.001853268,0.0004131314,0.0003491527,0.0006412728,0.000763488,0.0007237159,0.001569063],"category_scores_gemma":[0.0007798282,0.0005158903,0.001063607,0.0004273741,0.000664327,0.0006806773,0.0002880004,0.002425214,0.0003852823],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008907163,"about_ca_system_score_gemma":0.001251423,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005561069,"about_ca_topic_score_gemma":0.001728942,"domain_scores_codex":[0.9995444,0.0002182645,0.0000265746,0.00008684307,0.00005347206,0.00007037409],"domain_scores_gemma":[0.9994943,0.00007781485,0.0001226035,0.00005526078,0.00003045062,0.000219532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4792226,0.1324675,0.02295041,0.001234846,0.002399916,0.0006851513,0.0009398595,0.01022913,0.1391926,0.0002981666,0.003969928,0.2064099],"study_design_scores_gemma":[0.3375503,0.5998034,0.04209659,0.00003317895,0.0005961992,0.0008138274,0.00008871334,0.003728704,0.01160978,0.0001681423,0.003462379,0.00004870825],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977469,0.0007175088,0.0002394461,0.0001031117,0.00002204824,0.0006253443,0.0001518222,0.00004011889,0.0003537744],"genre_scores_gemma":[0.9959513,0.0006712481,0.001215257,0.0001734387,0.00004353532,0.0007385408,0.0005933225,0.00001220284,0.0006010818],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001853268,"threshold_uncertainty_score":0.007379234,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01519000231655764,"score_gpt":0.3402937606383409,"score_spread":0.3251037583217833,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}